Pharma major Novartis falls nearly 10%, heading for worst day on record after three drug trial setbacks
Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.
原文: https://www.cnbc.com/2026/09/08/novartis-novn-del-desiran-drug-trial.html
Last Update:
8 9 月, 2026